Authors

• Stefan H. Hohnloser (ORCID: https://orcid.org/0000-0001-5030-3315)
• A. John Camm (ORCID: https://orcid.org/0000-0002-2536-2871)
• Jonathan Paul Piccini (ORCID: https://orcid.org/0000-0003-0772-2404)
• Mattias Wieloch (ORCID: https://orcid.org/0000-0002-7425-6549)
• Paulus Kirchhof (ORCID: https://orcid.org/0000-0002-1881-0197)
• Christian Tobias Torp-Pedersen (ORCID: https://orcid.org/0000-0003-2892-6131)
• David S. McKindley (ORCID: https://orcid.org/0000-0002-4402-6814)
• Harry J.G.M. Crijns (ORCID: https://orcid.org/0000-0003-1073-5337)

Institutions

• Goethe University Frankfurt (DE)
• University of Copenhagen (DK)
• Universität Hamburg (DE)
• St George's, University of London (GB)
• Lund University (SE)
• Maastricht University Medical Centre (NL)
• Sanofi (France) (FR)
• Clinical Research Institute (US)
• Nordsjællands Hospital (DK)
• University Medical Center Hamburg-Eppendorf (DE)
• Sanofi (United States) (US)
• Duke Medical Center (US)
• German Centre for Cardiovascular Research (DE)
• University of Birmingham (GB)

Publication Details

Journal

EP Europace

Published

2025-03-28

DOI

https://doi.org/10.1093/europace/euaf080

Citations

3

Primary Topic

Atrial Fibrillation Management and Outcomes

Type

article

Field-Weighted Citation Impact

4.16

Funders

• Sanofi
• Sanofi Australia